Related Experiment Video
Updated: Jun 23, 2026

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
Why prevent, diagnose and treat congenital toxoplasmosis?
Rima McLeod1, Francois Kieffer, Mari Sautter
1Department of Ophthalmology and Visual Sciences, Committees on Immunology, Genetics, Molecular Medicine, The College, University of Chicago, Chicago, IL 60637, USA. rmcleod@midway.uchicago.edu
Abstract:
Evidence that prevention, diagnosis and treatment of toxoplasmosis is beneficial developed as follows: anti-parasitic agents abrogate Toxoplasma gondii tachyzoite growth, preventing destruction of infected, cultured, mammalian cells and cure active infections in experimental animals, including primates. They treat active infections in persons who are immune-compromised, limit destruction of retina by replicating parasites and thereby treat ocular toxoplasmosis and treat active infection in the fetus and infant. Outcomes of untreated congenital toxoplasmosis include adverse ocular and neurologic sequelae described in different countries and decades. Better outcomes are associated with treatment of infected infants throughout their first year of life. Shorter intervals between diagnosis and treatment in utero improve outcomes. A French approach for diagnosis and treatment of congenital toxoplasmosis in the fetus and infant can prevent toxoplasmosis and limit adverse sequelae. In addition, new data demonstrate that this French approach results in favorable outcomes with some early gestation infections. A standardized approach to diagnosis and treatment during gestation has not yet been applied generally in the USA. Nonetheless, a small, similar experience confirms that this French approach is feasible, safe, and results in favorable outcomes in the National Collaborative Chicago-based Congenital Toxoplasmosis Study cohort. Prompt diagnosis, prevention and treatment reduce adverse sequelae of congenital toxoplasmosis.
Insights
Prompt diagnosis and treatment of toxoplasmosis, especially congenital toxoplasmosis, significantly improve outcomes. Early intervention prevents severe ocular and neurologic damage in infants.
Area of Science:
- Medical Parasitology
- Infectious Diseases
- Public Health
Background:
- Toxoplasmosis, caused by *Toxoplasma gondii*, can lead to severe health issues, particularly congenital toxoplasmosis.
- Untreated congenital toxoplasmosis results in significant ocular and neurological complications.
- Existing treatments show efficacy in animal models and immunocompromised individuals.
Purpose of the Study:
- To evaluate the benefits of prevention, diagnosis, and treatment of toxoplasmosis.
- To assess the effectiveness of a French approach for diagnosing and treating congenital toxoplasmosis.
- To determine if this approach is feasible, safe, and yields favorable outcomes in a US cohort.
Main Methods:
- Review of evidence on anti-parasitic agents' efficacy against *Toxoplasma gondii*.
- Analysis of outcomes associated with treated vs. untreated congenital toxoplasmosis.
- Evaluation of a standardized French diagnostic and treatment protocol in a US study cohort.
Main Results:
- Anti-parasitic agents halt parasite growth, prevent cell destruction, and cure infections in experimental animals.
- Treatment of active infections in immunocompromised individuals and ocular toxoplasmosis is effective.
- The French approach for congenital toxoplasmosis demonstrated feasibility, safety, and favorable outcomes in the Chicago cohort.
Conclusions:
- Early diagnosis and treatment of toxoplasmosis, particularly congenital cases, are crucial for preventing severe sequelae.
- The French diagnostic and treatment approach offers a viable strategy for improving outcomes in congenital toxoplasmosis.
- Standardized, prompt intervention is key to reducing the adverse effects of toxoplasmosis.
Related Concept Videos
Toxoplasmosis
American Trypanosomiasis
Cytomegalovirus Disease
Sexually Transmitted Infections
Trichomoniasis
Teratogenicity
